DarioHealth Corp.

DRIO Healthcare Health Information Services

DarioHealth Corp.’s revenue for fiscal 2025 (year ended December 2025) was $22.4 million, down 17.3% from fiscal 2024.

Revenue
−3.58%
EPS
+76.0%
Free cash flow
−0.74%
Total debt
+1.85%

Quarter to June 2026, against a year earlier

2.43 0.30 −10.99%
Market cap
$26.7M
P/E
0.0×
Fwd P/E
−0.8×
Dividend yield
—
F-score
3/9
Altman Z
−5.72
Beneish M
−3.58
Dividend safety
n/a

DarioHealth Corp. (DRIO) P/E ratio

Alert me on P/E ratio

DarioHealth Corp. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 0.0× —
FY2018 0.0× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
Sep 2025 0.0× —
42 more quarters

Against its own ten years

Low 0.0× High 0.0×
Ten-year median 0.0×
Current reading's percentile 100

P/E ratio against peers

Company P/E ratio
HLTHQ Cue Health Inc. compare n/m
LFMD LifeMD, Inc. compare n/m
ONMD OneMedNet Corporation compare n/m
BFRG Bullfrog AI Holdings Inc. compare n/m
DRIO DarioHealth Corp. n/m
HCAT Health Catalyst, Inc. compare n/m
RNLXY Renalytix plc - Sponsored ADR compare n/m
BEAT HeartBeam, Inc. compare n/m
CCLD CareCloud, Inc. compare 17.8×
Health Information Services industry median 41.0×
Healthcare sector median 24.5×
Market median 17.8×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on DRIO